PATENT CLAIM ANALYSIS

Application Number: 15889578
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["546", "112000"]

Abstract:
The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a  Plasmodium  parasite, such as malaria.

Claim (Index 2):
The compound of  claim 1 , wherein L is selected from the group consisting of *\u2014C(O)N(R 2 ) and *\u2014N(R 2 )C(O)\u2014, wherein each R 2  is independently selected from hydrogen, C 1-4 alkyl, and R\u2014C 0-4 alkylene, and wherein R is selected from the group consisting of C 1-4 alkylamino, C 3-6 cycloalkyl, C 4-6 heterocycloalkyl and C 5-6 heteroaryl, each of which is unsubstituted or substituted with 1-2 substituents independently selected from the group consisting of halo, amino, hydroxyl, C 1-4 alkyl, C 1-4 alkoxy, oxo, and C 5-6  heteroaryl.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 88.0
- Lexical Diversity: 1.5102
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14443609', '14083203', '15220149', '15150038', '14382210']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8170941429532539
- 35 USC 102 Novelty (BERT): 0.6466745452678595
- Combined Prediction Score: 0.8000521831847144
- Mean Citation Score: 451.795378
- Max Citation Score: 627.8209
- Similarity Product: 585.7583019412756

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test